HU provided research conceptualisation, data curation, formal analysis, investigation, methodology, project administration, validation, and writing of the original draft. NA provided data curation, investigation, and writing–review and editing. NM contributed with supervision and writing–review and editing. CH provided data curation, validation, and writing–review & editing. JH provided visualisation and writing–review and editing. OS provided supervision of the research and contributed to writing–review & editing. HH contributed to writing–review & editing. All authors had unrestricted access to the data and take full responsibility for the decision to submit this manuscript for publication. The authors extend deepest gratitude to the hospital administrators (particularly Vitalii Schmyhelskyi and Mariana Svirchuk) of 1TMO for their support and commitment to prioritising the implementation of an antimicrobial resistance strategy amidst the immense challenges of conflict. The authors also thank the 1TMO IT, microbiology, and clinical pharmacy departments for time invested in the collection of data for the antibiogram. Finally, the authors would like to sincerely thank the government and non-government organizations who donated microbiology equipment and provided capacity building to the microbiology department. JBH declares grants or contracts from the Defense Advanced Research Projects Agency, and from the US Department of Defense (DoD), National Institutes of Health, and Commonwealth Serum Laboratories to his institution; payment or honoraria from Aspen Medical, Infrascan, Geneva Foundation, and Wake Forest Institute for Regenerative Medicine; support for attending meetings or travel from Duke University, Massachusetts General Hospital, Charles C Wolferth Memorial Lecture at the Baltimore American College of Surgeons Point Counterpoint, University of Chicago, University of Miami, and the Pennsylvania Trauma System Foundation John Pryor Lecture; has a board seat on Hemostatics, Zibrio, and the Prehospital Blood Transfusion Coalition Initiative, is on the data and safety monitoring board for DoD-funded Stem Cells for Compartment Syndrome; has stock or stock options in Qinflow, Hemostatics, Zibrio, and CCJ Medical; and is the coinventor of US patents 10262108 and 20220254486, and the junctional emergency tourniquet tool, for which he receives royalties from UT Health, Houston. All other authors declare no competing interests.